REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jeffrey Skolnik, MD
Inovio Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
60 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Instituto de Ginecología
Rosario, Santa Fe Province, Argentina
- Hospital Italiano de Buenos Aires
Buenos Aires, Argentina
- Dim Clínica Privada
Ramos Mejía, Argentina
- Centre Hospitalier Universitaire Ambroise Paré
Mons, Hainaut, Belgium
- Ziekenhuis Oost-Limburg
Genk, Limburg, Belgium
- Pärnu Hospital
Pärnu, Pärnumaa, Estonia
- East Tallinn Central Hospital Womens Clinic
Tallinn, Estonia
- Tartu University Hospital
Tartu, Estonia
- Kätilöopiston Sairaala
Helsinki, Finland
- Lääkäriasema Cantti Oy
Kuopio, Finland
- Elisabeth Krankenhaus Essen Gmbh
Essen, Germany
- Universitätsklinikum Hamburg Eppendorf
Hamburg, Germany
- Fondazione Policlinico Universitario A Gemelli
Rome, Lazio, Italy
- Istituto Europeo Di Oncologia
Milan, Italy
- Istituto Nazionale Dei Tumori
Milan, Italy
- Vilnius District Central Outpatient Clinic
Vilnius, Lithuania
- Vilnius University Hospital Santaros Klinikos
Vilnius, Lithuania
- Nuevo Hospital Civil de Guadalajara Dr. Juan I. Menchaca
Guadalajara, Jalisco, Mexico
- Liga Peruana de Lucha Contra El Cancer
Lima, Peru
- Unidad de Ensayos Clinicos (unidec) del Policlinico Universidad Nacional Mayor de San Marcos
Lima, Peru
- Perpetual Succour Hospital
Cebu, Philippines
- Niepubliczny Zakład Opieki Zdrowotnej Profimed
Lublin, Lublin Voivodeship, Poland
- Samodzielny Publiczny Szpital Kliniczny Nr 1 W Lublinie
Lublin, Lublin Voivodeship, Poland
- Centrum Medyczne Angelius Provita
Katowice, Poland
- Centro Hospitalar E Universitário de Coimbra Epe
Coimbra, Portugal
- Centro Hospitalar de Lisboa Norte, Epe - Hospital de Santa Maria
Lisbon, Portugal
- Puerto Rico Translational Research Center (prtrc)
Rio Piedras, Puerto Rico
- Mcm Gynped, S.R.O.
Dubnica nad Váhom, Slovakia
- Univerzitna Nemocnica Martin
Martin, Slovakia
- Lynette Reynders Private Practice
Centurion, Gauteng, South Africa
- University of Cape Town
Cape Town, South Africa
- Hospital Universitario de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain
- Hospital Clinico San Carlos
Madrid, Spain
- Hospital Universitario 12 de Octubre
Madrid, Spain
- Chulalongkorn University
Bangkok, Thailand
- Siriraj Hospital Mahidol University
Bangkok, Thailand
- Aberdeen Royal Infirmary - Ppds
Aberdeen, United Kingdom
- St Marys Hospital
London, United Kingdom
- Mesa Obstetricians and Gynecologist
Mesa, Arizona, United States
- Women'S Health Research
Scottsdale, Arizona, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Jun 2017
- Primary completion
- 8 Jul 2020
- Completion
- 6 Apr 2021
- Last update posted
- 27 Jul 2023
- Registered enrollment
- 201
- Registry id
- NCT03185013
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.